Assignee
89BIO INC
US·4 granted patents·4 pending applications·5 citations·filing 2022–2025
Top patents by PatentIndex Score
8 records- 0189US11596669B2Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates89BIO INC·Filed 2022·Granted Mar 7, 2023·4 cites·13 claims
- 0285US11850275B2Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates89BIO INC·Filed 2023·Granted Dec 26, 2023·1 cites·20 claims
- 0378US12350314B2Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates89BIO INC·Filed 2023·Granted Jul 8, 2025·0 cites·9 claims
- 0473US2025381246A1Liquid formulations comprising mutant fgf-21 peptide pegylated conjugates89BIO INC·Filed 2025·Application pending·0 cites
- 0565US2025170249A1Compositions and methods of treatment for severe hypertriglyceridemia89BIO INC·Filed 2024·Application pending·0 cites
- 0664US12036284B2Compositions and methods of treatment for severe hypertriglyceridemia89BIO INC·Filed 2023·Granted Jul 16, 2024·0 cites·27 claims
- 0758US2024327447A1Chemical synthesis of cytidine-5'-monophospho-n-glycyl-sialic acid89BIO INC·Filed 2024·Application pending·0 cites
- 0843US2025325679A1Compositions and methods of treatment for severe hypertriglyceridemia89BIO INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when 89BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →